Chenfeng Xu

A sequentially responsive and structure-transformable nanoparticle with a comprehensively improved 'CAPIR cascade' for enhanced antitumor effect.

Chenfeng Xu, Yu Sun, Yulin Yu, 2019, Nanoscale.

Transformable Nanoparticle‐Enabled Synergistic Elicitation and Promotion of Immunogenic Cell Death for Triple‐Negative Breast Cancer Immunotherapy

Chenfeng Xu, Yu Sun, Yulin Yu, 2019, Advanced Functional Materials.

Star-shaped polymer of β‑cyclodextrin-g-vitamin E TPGS for doxorubicin delivery and multidrug resistance inhibition.

Chenfeng Xu, Conglian Yang, Zhiping Zhang, 2018, Colloids and surfaces. B, Biointerfaces.

Selective self‐induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis

Chenfeng Xu, Yu Sun, Yulin Yu, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Tumor-targeted docetaxel-loaded hyaluronic acid-quercetin polymeric micelles with p-gp inhibitory property for hepatic cancer therapy

Jianping Zhou, Jing Yao, Chenfeng Xu, 2016 .

Cdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunity

Chenfeng Xu, Zhiping Zhang, Wei Huang, 2019, Acta pharmaceutica Sinica. B.

Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy.

Chenfeng Xu, Zhiping Zhang, Q. Hu, 2018, Molecular pharmaceutics.

Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy.

Chenfeng Xu, Xing Wang, Zifu Li, 2023, Journal of controlled release : official journal of the Controlled Release Society.